Press Room

2025 AIChE Annual meeting

Start
Sunday, November 02, 2025 - 17:37
End
Thursday, November 06, 2025 - 17:38
Location: Boston, United States

Meet Hovione team at the 2025 AIChE Annual Meeting and find their exciting presentations and Hovione’s latest research and innovations. The AIChE Annual Meeting is an educational forum covering a wide range of topics relevant to cutting-edge research, new technologies, and emerging growth areas in chemical engineering. We look forward to meeting academic and industry experts and exchanging knowledge.

Date: November 2

Oral communication

Title: Early Development of a Modified Release Formulation and Process for Continuous Direct Compression: A Case Study (NH10 case study) 

Presenting Author: Ricardo Sousa, Senior Scientist

3:48 PM - Room 308 (Hynes Convention Center)

Oral communication

Title: Continuous Dosing and Blending (CDB) As a Laboratory Tool to Expedite Process Development

Presenting Author: Ana Costa, Senior Scientist

4:06 PM - Room 308 (Hynes Convention Center)

Oral communication

Title: Exploring Synergies between SMEs and AI-Powered Tools in Reaction Optimization

Presenting Author: Pedro Valente, Fellow Scientist  Modeling & Rapid Prototyping

4:45 PM - Room 309 (Third Level, Hynes Convention Center)



Date: November 3

Poster

Title: GMP Flow Chemistry Platforms: A CDMO Perspective on Enabling the Next Generation of Clinical-Stage API Manufacturing

Presenting Author: Rudi Oliveira, Senior Scientist

3:30 PM - Room Exhibit Hall C (Second Level, Hynes Convention Center)

Oral communication

Title: From offline to inline: Advancing inhalation drug manufacturing with real-time particle size monitoring and solids concentration modelling

Presenting Author: Nichal Gentilal, Scientist

8:54 AM - Room 313 (Hynes Convention Center)

 

Date: November 4

Oral communication

Title: Scaling Down Fluid Bed Drying: A Comparative Study of Mini-Glatt and Consigma™-1

Presenting Author: Ricardo Sousa, Senior Scientist

4:42 PM - Room Liberty Ballroom B (2, Sheraton Boston)

Oral communication

Title: Process development & control strategies with PAT and Soft-sensors: A solvent swap case-study

Presenting Author: Pedro Valente, Fellow Scientist  Modeling & Rapid Prototyping

4:42 PM - Room 309 (Third Level, Hynes Convention Center)

Oral communication

Title: Exploring Novel Excipients in the Transition from Batch to Continuous Tableting (CT)

Presenting Author: Ana Costa, Senior Scientist

4:54 PM - Room 308 (Third Level, Hynes Convention Center)

Oral communication

Title: Safety By Design: Leveraging Data-Rich Experimentation and Process Modeling Towards a Digital Twin

Presenting Author: Rudi Oliveira, Senior Scientist

5:00 PM - Room 309 (Hynes Convention Center)

 

Hovione Team Members will also chair the following sessions:

Nov. 2

Title: Continuous Processing in Drug Product

Presenting Author: Sarang Oka, Fellow Scientist - Technology Intensification  

3:30 PM – Room 308 (Hynes Convention Center)

Nov. 3

Title: Particle Characterization            

Presenting Author: Sarang Oka, Fellow Scientist - Technology Intensification 

8:00 AM - Room Independence Ballroom West

Nov. 3

Title: Advances in Smart Monitoring, Optimization and Control of Process Manufacturing

Presenting Author: Ankita Naik, Modeling and PAT Scientist

8:00 AM - Room 304 (Hynes Convention Center)

 

Contact our experts today to find out more about the work we are doing to support our customers’ projects, solving complex challenges, and bringing needed therapies to life.

Let’s discuss your project together.

schedule a meeting

 

 

 

 

 

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026